Gene · 8607
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction and validation of a prognostic model associated with chromatin remodeling in hepatocellular carcinoma. | Transl Cancer Res | 2026 | 41815170 | PubTator, text mining | PubMed |
| The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer. | Virol J | 2026 | 41787535 | PubTator, text mining | PubMed |
| Recognition and remodelling of nucleosomes and hexasomes by the human INO80 complex. | Nucleic Acids Res | 2026 | 41775336 | PubTator, text mining | PubMed |
| An integrative structural biology approach reveals the dynamic organization of the R2SP quaternary chaperone complex. | Nat Commun | 2026 | 41667496 | PubTator, text mining | PubMed |
| Identification of Small Extracellular Vesicle (sEV)-Related Genes and the Establishment of Diagnostic Models for Esophageal Cancer. | Curr Med Chem | 2026 | 41664333 | PubTator, text mining | PubMed |
| Discovery of RUVBL1 as a Target of the Marine Alkaloid Caulerpin via MS-Based Functional Proteomics. | Mar Drugs | 2026 | 41590734 | PubTator, text mining | PubMed |
| A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice. | Nucleic Acids Res | 2026 | 41574437 | PubTator, text mining | PubMed |
| RUVBL1-mediated mTORC1 activation drives tumour progression and immune evasion for oral squamous cell carcinoma. | Life Sci | 2026 | 41455509 | PubTator, text mining | PubMed |
| PIH1D1 and RPAP3, Components of the PAQosome: Emerging Roles in Cellular Physiology. | Mol Cell Biol | 2026 | 41424038 | PubTator, text mining | PubMed |
| A small molecule targets LIC1 to suppress lung tumor growth by inducing autophagy. | Nat Chem Biol | 2026 | 41102409 | PubTator, text mining | PubMed |
| KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. | Nat Commun | 2025 | 41241675 | PubTator, text mining | PubMed |
| Proteomics of Duchenne Muscular Dystrophy Patient iPSC-Derived Skeletal Muscle Cells Reveal Differential Expression of Cytoskeletal and Extracellular Matrix Proteins. | Cells | 2025 | 41227334 | PubTator, text mining | PubMed |
| Cannabinoid Receptor Type 2 Agonist JWH-133 Stimulates Antiviral Factors and Decreases Proviral, Inflammatory, and Neurotoxic Proteins in HIV-Infected Macrophage Secretome. | Int J Mol Sci | 2025 | 41226631 | PubTator, text mining | PubMed |
| Correction to "Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis". | Adv Sci (Weinh) | 2025 | 41199425 | PubTator, text mining | PubMed |
| RUVBL1: A promising prognostic indicator for HPV-associated oral squamous cell carcinoma. | Cancer Treat Res Commun | 2025 | 41168028 | PubTator, text mining | PubMed |
| The leaves fall, yet the tree endures. | Cell Mol Life Sci | 2025 | 41148281 | PubTator, text mining | PubMed |
| Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer. | Clin Transl Med | 2025 | 41020311 | PubTator, text mining | PubMed |
| Lnc-THAP7-AS1 suppresses the ovarian cancer progression by targeting miR-92b-5p/fatty acid 2-hydroxylase signal axis. | Transl Oncol | 2025 | 40876104 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 5 sustains Tip60-EP400 complex via SRSF1 in Merkel cell carcinoma. | Life Sci Alliance | 2025 | 40846633 | PubTator, text mining | PubMed |
| The p400 complex promotes HIV-1 latency by suppressing viral transcription and altering the host cell state. | Nucleic Acids Res | 2025 | 40842241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/papers?page=2